BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32774053)

  • 1. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies.
    Zhang Q; Lou Y; Bai XL; Liang TB
    World J Gastroenterol; 2020 Jul; 26(26):3720-3736. PubMed ID: 32774053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer.
    Yang C; Zhang S; Cheng Z; Liu Z; Zhang L; Jiang K; Geng H; Qian R; Wang J; Huang X; Chen M; Li Z; Qin W; Xia Q; Kang X; Wang C; Hang H
    Genome Med; 2022 Dec; 14(1):142. PubMed ID: 36527145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma.
    Huang A; Zhao X; Yang XR; Li FQ; Zhou XL; Wu K; Zhang X; Sun QM; Cao Y; Zhu HM; Wang XD; Yang HM; Wang J; Tang ZY; Hou Y; Fan J; Zhou J
    J Hepatol; 2017 Aug; 67(2):293-301. PubMed ID: 28323123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma.
    Xu FQ; Dong MM; Wang ZF; Cao LD
    Front Immunol; 2023; 14():1083069. PubMed ID: 36776894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinoma.
    Huang A; Wang YP; Wang J; Fu PY; Zhang X; Cao Y; Fan J; Yang XR; Zhou J
    J Gastrointest Oncol; 2020 Feb; 11(1):112-120. PubMed ID: 32175113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation.
    Nie P; Zhang J; Miao W; Duan S; Wang T; Zhang J; Gu J; Wang N; Zhang R; Wang X; Yang G; Rao W; Wang Z
    Eur Radiol; 2023 Sep; 33(9):6608-6618. PubMed ID: 37012548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
    Nguyen PHD; Ma S; Phua CZJ; Kaya NA; Lai HLH; Lim CJ; Lim JQ; Wasser M; Lai L; Tam WL; Lim TKH; Wan WK; Loh T; Leow WQ; Pang YH; Chan CY; Lee SY; Cheow PC; Toh HC; Ginhoux F; Iyer S; Kow AWC; Young Dan Y; Chung A; Bonney GK; Goh BKP; Albani S; Chow PKH; Zhai W; Chew V
    Nat Commun; 2021 Jan; 12(1):227. PubMed ID: 33431814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.
    Chen J; Kaya NA; Zhang Y; Kendarsari RI; Sekar K; Lee Chong S; Seshachalam VP; Ling WH; Jin Phua CZ; Lai H; Yang H; Lu B; Lim JQ; Ma S; Chew SC; Chua KP; Alvarez JJS; Wu L; Ooi L; Chung AY; Cheow PC; Kam JH; Kow AW; Ganpathi IS; Bunchaliew C; Thammasiri J; Koh PS; Ong DB; Lim J; de Villa VH; Dela Cruz RD; Loh TJ; Wan WK; Leow WQ; Yang Y; Liu J; Skanderup AJ; Pang YH; Soon GST; Madhavan K; Lim TK; Bonney G; Goh BKP; Chew V; Dan YY; Toh HC; Foo RS; Tam WL; Zhai W; Chow PK
    J Hepatol; 2024 May; ():. PubMed ID: 38782118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
    Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
    J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
    Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
    Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma.
    Luo S; Jia Y; Zhang Y; Zhang X
    JHEP Rep; 2023 Jun; 5(6):100754. PubMed ID: 37234275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Epigenetic Heterogeneity in Normal Liver Homeostasis and Its Implications for Liver Disease and Hepatocellular Cancer.
    Hlady RA; Robertson KD
    Semin Liver Dis; 2018 Feb; 38(1):41-50. PubMed ID: 29471564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.
    Oura K; Morishita A; Tani J; Masaki T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.
    Zhou HY; Luo Y; Chen WD; Gong GZ
    J Gastroenterol Hepatol; 2015 Jun; 30(6):977-83. PubMed ID: 25689418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas.
    Zhang Q; Lou Y; Yang J; Wang J; Feng J; Zhao Y; Wang L; Huang X; Fu Q; Ye M; Zhang X; Chen Y; Ma C; Ge H; Wang J; Wu J; Wei T; Chen Q; Wu J; Yu C; Xiao Y; Feng X; Guo G; Liang T; Bai X
    Gut; 2019 Nov; 68(11):2019-2031. PubMed ID: 31227589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
    Ahmad M; Dhasmana A; Harne PS; Zamir A; Hafeez BB
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1175-1185. PubMed ID: 35189322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities.
    Kalasekar SM; VanSant-Webb CH; Evason KJ
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of genetic heterogeneity in hepatocellular cancer.
    Suresh A; Dhanasekaran R
    Adv Cancer Res; 2022; 156():103-135. PubMed ID: 35961697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.
    Liu D; Song T
    Biosci Trends; 2021 Jul; 15(3):142-147. PubMed ID: 33716267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.